Dr. Raymond Borland, MD
What this data tells you about Dr. Borland
Dr. Raymond Borland is an urology physician in Palm Beach Gardens, FL, with 19 years in practice. Based on federal Medicare data, Dr. Borland performed 17,047 Medicare services across 7,674 unique beneficiaries.
Between the years covered by Open Payments, Dr. Borland received a total of $3,990 from 46 pharmaceutical and/or device companies across 167 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Borland is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 5,650 | $2 | $4 |
| Manual urinalysis test with examination using microscope, non-automated | 1,893 | $4 | $15 |
| Office visit, established patient (20-29 min) | 1,844 | $71 | $125 |
| Office visit, established patient (30-39 min) | 1,576 | $98 | $175 |
| Urinalysis, manual | 1,309 | $3 | $5 |
| PSA test (prostate cancer screening) | 1,037 | $18 | $68 |
| Blood draw (venipuncture) | 871 | $8 | $11 |
| Bladder ultrasound after voiding | 551 | $9 | $100 |
| Diagnostic exam of bladder and urethra using an endoscope | 345 | $183 | $500 |
| Limited ultrasound scan behind abdominal cavity | 301 | $47 | $200 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 231 | $136 | $800 |
| New patient office visit (45-59 min) | 182 | $124 | $240 |
| Psa (prostate specific antigen) measurement, free | 159 | $18 | $68 |
| Instillation of anti-cancer drug into bladder | 122 | $72 | $425 |
| Simple insertion of temporary bladder tube | 110 | $49 | $200 |
| New patient office visit (30-44 min) | 104 | $85 | $180 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 96 | $26 | $80 |
| Hospital follow-up visit, moderate complexity | 80 | $63 | $150 |
| Ceftriaxone antibiotic injection | 72 | $0 | $25 |
| Electronic assessment of bladder emptying | 68 | $9 | $225 |
| Testosterone (hormone) level, total | 44 | $25 | $60 |
| Office visit, established patient (10-19 min) | 40 | $44 | $100 |
| Ultrasound scan of pelvic region through rectum | 39 | $107 | $245 |
| Injection of ureter for imaging | 31 | $23 | $65 |
| Insertion of stent in ureter using an endoscope | 27 | $82 | $1,600 |
| Office visit, established patient, complex (40-54 min) | 26 | $149 | $200 |
| Initial hospital admission, high complexity | 26 | $145 | $300 |
| Complete ultrasound scan of pelvis | 25 | $78 | $200 |
| Catheterization for collection of specimen, single patient, all places of service | 22 | $8 | $15 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 19 | $242 | $800 |
| Drug injection, under skin or into muscle | 19 | $12 | $35 |
| Initial hospital admission, moderate complexity | 18 | $103 | $250 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 17 | $347 | $1,125 |
| Biopsy of prostate gland | 17 | $155 | $400 |
| Ultrasonic guidance for needle placement | 17 | $48 | $300 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 16 | $237 | $1,400 |
| Complete laser vaporization of prostate including control of bleeding using an endoscope | 16 | $585 | $2,500 |
| Ultrasound scan of scrotum | 16 | $74 | $175 |
| Injection procedure to cause erection | 11 | $77 | $175 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Borland is a clinical cardiology specialist, with above-average Medicare volume (top 7% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Borland experienced with bcg treatment for bladder cancer?
Does Dr. Borland receive payments from pharmaceutical companies?
How do Dr. Borland's costs compare to other urology physicians in Palm Beach Gardens?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology